Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection

Publisher： Karger

E-ISSN： 1664-5553|5|3|221-232

ISSN： 2235-1795

Source： Liver Cancer, Vol.5, Iss.3, 2016-05, pp. : 221-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials in Hepatocellular Carcinoma: An Update

By  

Liver Cancer, Vol. 2, Iss. 3-4, 2013-08 ,pp. : 345-364

Karger

Access to resources Recommend Favorite

Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice

By  

Digestive Diseases, Vol. 33, Iss. 5, 2015-09 ,pp. : 668-674

Karger

Access to resources Recommend Favorite

Clinical Staging of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 27, Iss. 2, 2009-06 ,pp. : 131-141

Karger

Access to resources Recommend Favorite

Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future

By  

Liver Cancer, Vol. 3, Iss. 1, 2014-02 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Clinical Trials and Dipyridamole Formulation Selection

By  

Cerebrovascular Diseases, Vol. 23, Iss. 1, 2006-11 ,pp. : 72-73

Karger

Access to resources Recommend Favorite